Literature DB >> 2872726

Cytotoxic drugs: their clinical application to the rheumatic diseases.

P J Clements, J Davis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872726     DOI: 10.1016/0049-0172(86)90020-x

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  11 in total

1.  Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.

Authors:  I Martin-Suarez; D D'Cruz; M Mansoor; A P Fernandes; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

Review 2.  The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.

Authors:  L E Hart; P Tugwell
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

3.  [Not Available].

Authors:  C Grondin
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

Review 4.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

5.  Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis.

Authors:  H J Haga; D D'Cruz; R Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

Review 6.  Rational use of disease-modifying antirheumatic drugs.

Authors:  D E Furst
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

7.  Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine.

Authors:  H Bliddal; P Helin
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

Review 8.  Treatment of systemic lupus erythematosus: which options do we have for therapy regimens?

Authors:  L Kater; R H Derksen; R J Hené
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 9.  Rheumatoid arthritis in the aged. Incidence and optimal management.

Authors:  G Nesher; T L Moore
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

Review 10.  Small-vessel vasculitis: therapeutic management.

Authors:  Carol A Langford
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.